Neuroprosthetic Device for Improving Issues Caused by Diabetic Neuropathy With Specifically Designed Neural Stimulation

Last updated: June 18, 2024
Sponsor: Institute Mihajlo Pupin
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neurologic Disorders

Treatment

Somatosensory feedback

Clinical Study ID

NCT06471517
DiabeticStim
  • Ages > 18
  • All Genders

Study Summary

Neuropathy refers to a condition that results from damage to the peripheral nerves.The most common cause of it is diabetes mellitus, metabolic disorder that affects more than 422 million individuals worldwide, putting a huge strain on the healthcare system and up to 50% of these individuals will develop neuropathy. Peripheral neuropathy is characterized by sensory nerve abnormalities such as an impaired sense of touch. Sensory loss in feet can lead to functional deficits during gait, low balance, and increased risk of falls and is considered the strongest risk factor for diabetic foot ulceration. Moreover, these patients usually also suffer from neuropathic pain, which is believed to be associated with aberrant sensory input.

With this in mind, the study aims to understand the effects of restoring sensation lost to neuropathy using transcutaneous electrical stimulation. Additionally, the investigators aim to understand if electrical stimulation of the damaged nerves can reduce health consequences such as chronic pain.

To achieve this, the investigators have developed a wearable sensory restoration system that can restore lost sensation with non-invasive, precisely controlled electrical stimulation through electrodes integrated into the sock garment. A system is composed of a system controller that communicates via Bluetooth with force-sensitive insoles placed in the shoes and neurostimulators directly connected to electrode array socks. Based on the insole recordings the stimulation parameters are defined in real-time, making it a closed-loop system for restoring somatotopic sensory feedback.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed polyneuropathy

  • Ability to stand and walk unassisted.

  • Sensory loss in the feet

Exclusion

Exclusion Criteria:

  • Open ulcers on the feet

  • Pregnancy

  • History of or current psychological diseases that include schizophrenia and majordepression

  • Hypersensitivity to electrical stimulation

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Somatosensory feedback
Phase:
Study Start date:
June 13, 2024
Estimated Completion Date:
July 31, 2025

Connect with a study center

  • Clinics for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia

    Belgrade,
    Serbia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.